Cite

HARVARD Citation

    Touma, Z. et al. (n.d.). 10 Performance of SLEDAI-2K Responder Index-50 in a Randomized Placebo-Controlled Trial with Ustekinumab (UST) in Systemic Lupus Erythematosus. Lupus science & medicine. p. A9. [Online]. 
  
Back to record